Craft

Tactile Medical

Stock Price

$14.2

2023-09-19

Market Capitalization

$333.1 M

2023-09-19

Revenue

$246.8 M

FY, 2022

Tactile Medical Summary

Company Summary

Overview
Tactile Medical is a leader in treatment options for lymphedema and venous ulcer therapies. Tactile Medical develops advanced home therapy devices to improve health and quality of life for patients with chronic swelling conditions. The Company's offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates, and clinicians.
Type
Public
Status
Active
Founded
2006
HQ
Minneapolis, MN, US | view all locations
Website
http://www.tactilemedical.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Daniel L. Reuvers

    Daniel L. Reuvers, President & Chief Executive Officer, Director

    • Brent A. Moen

      Brent A. Moen, Chief Finanical Officer

      • Thomas F. O'Donnell

        Thomas F. O'Donnell, Chief Medical Officer

        • R. Jay Stracke

          R. Jay Stracke, Vice President of Reimbursement and Payer Relations

        LocationsView all

        1 location detected

        • Minneapolis, MN HQ

          United States

          3701 Wayzata Blvd #300

        Tactile Medical Financials

        Summary Financials

        Revenue (Q2, 2023)
        $68.3M
        Gross profit (Q2, 2023)
        $48.3M
        Net income (Q2, 2023)
        ($100.0K)
        Cash (Q2, 2023)
        $63.2M
        EBIT (Q2, 2023)
        $2.1M
        Enterprise value
        $339.5M

        Footer menu